News in brief - August 2014

Other new launches, licence changes and updates relevant to general practice.

Fenistil (penciclovir) is used to treat herpes simplex virus infection of the lips and face in adults and children over 12 years of age. | SCIENCE PHOTO LIBRARY
Fenistil (penciclovir) is used to treat herpes simplex virus infection of the lips and face in adults and children over 12 years of age. | SCIENCE PHOTO LIBRARY
  • Janssen-Cilag has launched Sylvant (siltuximab) for the treatment of multicentric Castleman's disease in adults who are HIV-negative and human herpesvirus-8 negative.
  • The cold sore cream Fenistil (penciclovir) has been reclassified from a P medicine to a GSL.
  • Arzerra (ofatumumab) is now indicated in combination with chlorambucil or bendamustine for the treatment of chronic lymphocytic leukaemia in previously untreated patients ineligible for fludarabine-based therapy.

Follow MIMS on Twitter

Sign up for MIMS bulletins


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.